- Alcon, the eye division of Novartis, has entered into an agreement with Google to license its ‘smart lens’ technology.
- The application of smart lens technology will involve non-invasive sensors, microchips and other miniaturized electronics, which will be embedded in contact lenses.
- Alcon’s goal is to use technology to help manage diseases. Google’s miniaturized electronics and other technology are seen as a way to make progress on this goal.
Novartis is focusing on using the smart lens technology in two areas, including putting the "smart" contact lenses in the eyes of individuals with diabetes to measure glucose levels in the body, as well as helping restore autofocus capabilities in people with presbyopia. "Our dream is to use the latest technology in the miniaturization of electronics to help improve the quality of life for millions of people," said Sergey Brin, a Google co-founder.